Topical Sirolimus 0.1% as Off Label Treatment of Kaposi’s Sarcoma. Dermatology Practical & Conceptual, [S. l.], v. 14, n. 3, p. e2024201, 2024. DOI: 10.5826/dpc.1403a201. Disponível em: https://www.dpcj.org/index.php/dpc/article/view/4292.. Acesso em: 15 jan. 2025.